One shot to control Pain: Decreasing postoperative opioid use in gynecologic oncology patients with intrathecal opioid injection

Objectives: To determine whether regional anesthesia with single-shot intrathecal opioid injections (ITO) reduce postoperative pain and intravenous (IV) opioid use after exploratory laparotomy in major gynecologic surgeries. Methods: A retrospective chart review of 315 consecutive cases of patients...

Full description

Bibliographic Details
Main Authors: Yevgeniya Ioffe, Ruofan Yao, Eileen Hou, Michelle Wheeler, Mohamed Nour, Wei Yun Wang, Linda Hong
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:Gynecologic Oncology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578921001624
_version_ 1818398787974987776
author Yevgeniya Ioffe
Ruofan Yao
Eileen Hou
Michelle Wheeler
Mohamed Nour
Wei Yun Wang
Linda Hong
author_facet Yevgeniya Ioffe
Ruofan Yao
Eileen Hou
Michelle Wheeler
Mohamed Nour
Wei Yun Wang
Linda Hong
author_sort Yevgeniya Ioffe
collection DOAJ
description Objectives: To determine whether regional anesthesia with single-shot intrathecal opioid injections (ITO) reduce postoperative pain and intravenous (IV) opioid use after exploratory laparotomy in major gynecologic surgeries. Methods: A retrospective chart review of 315 consecutive cases of patients who underwent an exploratory laparotomy on the gynecologic oncology service from July 2015 to January 2018 was conducted. Single-shot ITO was offered to all patients undergoing open abdominal surgery. The primary outcomes of interest were IV opioid use in morphine equivalents during the first 48 hours after surgery. Univariate analyses were performed to estimate the effect of ITO on IV opioid use at 0, 6, 12, 24 and 48 hours after surgery. Longitudinal regression analyses were performed to estimate the effect of ITO on changes in outcomes of interest over time, adjusting for potential confounders. Results: 35% (110/315) received ITO preoperatively. There were no differences in patient age, BMI, previous number of abdominal surgeries, history of opioid dependence, type of gynecologic surgery, or total EBL between the ITO and control groups. Preoperative ITO was associated with a significantly lower IV opioid requirement between 0 and 6 hours after surgery (9.7 ± 8.1 vs 14.3 ± 11.5, p < 0.0001) and between 6 and 12 hours after surgery (2.7 ± 3.8 vs 5.4 ± 9.5, p = 0.0054). There was no statistically significant difference in total hospital stay opioid requirement but median length of stay was increased by 1 day. Conclusions: Preoperative administration of ITO reduced IV opioid requirement in the first 12 hours postoperatively but was associated with median 1 day increase in hospital stay.
first_indexed 2024-12-14T07:10:21Z
format Article
id doaj.art-5abf07c7b89c44ebbb27430a53a05238
institution Directory Open Access Journal
issn 2352-5789
language English
last_indexed 2024-12-14T07:10:21Z
publishDate 2021-11-01
publisher Elsevier
record_format Article
series Gynecologic Oncology Reports
spelling doaj.art-5abf07c7b89c44ebbb27430a53a052382022-12-21T23:11:53ZengElsevierGynecologic Oncology Reports2352-57892021-11-0138100858One shot to control Pain: Decreasing postoperative opioid use in gynecologic oncology patients with intrathecal opioid injectionYevgeniya Ioffe0Ruofan Yao1Eileen Hou2Michelle Wheeler3Mohamed Nour4Wei Yun Wang5Linda Hong6Loma Linda University Medical Center, 11234 Anderson Street, Loma Linda, CA, 92354Loma Linda University Medical Center, 11234 Anderson Street, Loma Linda, CA, 92354Advocate Outpatient Center, 9555 S. 52nd Ave, 2nd floor, Oak Lawn, IL, 60453Loma Linda University Medical Center, 11234 Anderson Street, Loma Linda, CA, 92354Kaiser Permanente West Los Angeles Medical Center, 6041 Cadillac Avenue, Los Angeles, CA 90034University of Washington, 1959 NE Pacific Street, BB-1469, Seattle, WA, 98195Loma Linda University Medical Center, 11234 Anderson Street, Loma Linda, CA, 92354; Corresponding author at: 11234 Anderson St, Loma Linda, CA, 92354.Objectives: To determine whether regional anesthesia with single-shot intrathecal opioid injections (ITO) reduce postoperative pain and intravenous (IV) opioid use after exploratory laparotomy in major gynecologic surgeries. Methods: A retrospective chart review of 315 consecutive cases of patients who underwent an exploratory laparotomy on the gynecologic oncology service from July 2015 to January 2018 was conducted. Single-shot ITO was offered to all patients undergoing open abdominal surgery. The primary outcomes of interest were IV opioid use in morphine equivalents during the first 48 hours after surgery. Univariate analyses were performed to estimate the effect of ITO on IV opioid use at 0, 6, 12, 24 and 48 hours after surgery. Longitudinal regression analyses were performed to estimate the effect of ITO on changes in outcomes of interest over time, adjusting for potential confounders. Results: 35% (110/315) received ITO preoperatively. There were no differences in patient age, BMI, previous number of abdominal surgeries, history of opioid dependence, type of gynecologic surgery, or total EBL between the ITO and control groups. Preoperative ITO was associated with a significantly lower IV opioid requirement between 0 and 6 hours after surgery (9.7 ± 8.1 vs 14.3 ± 11.5, p < 0.0001) and between 6 and 12 hours after surgery (2.7 ± 3.8 vs 5.4 ± 9.5, p = 0.0054). There was no statistically significant difference in total hospital stay opioid requirement but median length of stay was increased by 1 day. Conclusions: Preoperative administration of ITO reduced IV opioid requirement in the first 12 hours postoperatively but was associated with median 1 day increase in hospital stay.http://www.sciencedirect.com/science/article/pii/S2352578921001624Intrathecal opioidPostoperative painGynecologic oncologyExploratory laparotomy
spellingShingle Yevgeniya Ioffe
Ruofan Yao
Eileen Hou
Michelle Wheeler
Mohamed Nour
Wei Yun Wang
Linda Hong
One shot to control Pain: Decreasing postoperative opioid use in gynecologic oncology patients with intrathecal opioid injection
Gynecologic Oncology Reports
Intrathecal opioid
Postoperative pain
Gynecologic oncology
Exploratory laparotomy
title One shot to control Pain: Decreasing postoperative opioid use in gynecologic oncology patients with intrathecal opioid injection
title_full One shot to control Pain: Decreasing postoperative opioid use in gynecologic oncology patients with intrathecal opioid injection
title_fullStr One shot to control Pain: Decreasing postoperative opioid use in gynecologic oncology patients with intrathecal opioid injection
title_full_unstemmed One shot to control Pain: Decreasing postoperative opioid use in gynecologic oncology patients with intrathecal opioid injection
title_short One shot to control Pain: Decreasing postoperative opioid use in gynecologic oncology patients with intrathecal opioid injection
title_sort one shot to control pain decreasing postoperative opioid use in gynecologic oncology patients with intrathecal opioid injection
topic Intrathecal opioid
Postoperative pain
Gynecologic oncology
Exploratory laparotomy
url http://www.sciencedirect.com/science/article/pii/S2352578921001624
work_keys_str_mv AT yevgeniyaioffe oneshottocontrolpaindecreasingpostoperativeopioiduseingynecologiconcologypatientswithintrathecalopioidinjection
AT ruofanyao oneshottocontrolpaindecreasingpostoperativeopioiduseingynecologiconcologypatientswithintrathecalopioidinjection
AT eileenhou oneshottocontrolpaindecreasingpostoperativeopioiduseingynecologiconcologypatientswithintrathecalopioidinjection
AT michellewheeler oneshottocontrolpaindecreasingpostoperativeopioiduseingynecologiconcologypatientswithintrathecalopioidinjection
AT mohamednour oneshottocontrolpaindecreasingpostoperativeopioiduseingynecologiconcologypatientswithintrathecalopioidinjection
AT weiyunwang oneshottocontrolpaindecreasingpostoperativeopioiduseingynecologiconcologypatientswithintrathecalopioidinjection
AT lindahong oneshottocontrolpaindecreasingpostoperativeopioiduseingynecologiconcologypatientswithintrathecalopioidinjection